140 related articles for article (PubMed ID: 21729583)
1. [Research advance of p53 gene in mantle cell lymphoma].
Zhou LT; Zhu JB
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Jun; 19(3):835-8. PubMed ID: 21729583
[TBL] [Abstract][Full Text] [Related]
2. Pathogenesis of mantle-cell lymphoma: all oncogenic roads lead to dysregulation of cell cycle and DNA damage response pathways.
Fernàndez V; Hartmann E; Ott G; Campo E; Rosenwald A
J Clin Oncol; 2005 Sep; 23(26):6364-9. PubMed ID: 16155021
[TBL] [Abstract][Full Text] [Related]
3. Loss of the p53 tumor suppressor activity is associated with negative prognosis of mantle cell lymphoma.
Stefancikova L; Moulis M; Fabian P; Ravcukova B; Vasova I; Muzik J; Malcikova J; Falkova I; Slovackova J; Smardova J
Int J Oncol; 2010 Mar; 36(3):699-706. PubMed ID: 20126990
[TBL] [Abstract][Full Text] [Related]
4. Allelic genotyping reveals a hierarchy of genomic alterations in mantle cell lymphoma associated to cell proliferation.
Hutter G; Scheubner M; Ott G; Zimmermann Y; Hübler K; Roth S; Stilgenbauer S; Kalla J; Stöcklein H; Hiddemann W; Dreyling M
Ann Hematol; 2009 Sep; 88(9):821-8. PubMed ID: 19137297
[TBL] [Abstract][Full Text] [Related]
5. Real-time RT-PCR assay for quantifying cyclin D1 mRNA in B-cell non-Hodgkin's lymphomas.
Medeiros LJ; Hai S; Thomazy VA; Estalilla OC; Romaguera J; Luthra R
Mod Pathol; 2002 May; 15(5):556-64. PubMed ID: 12011261
[TBL] [Abstract][Full Text] [Related]
6. Clinical, morphologic, phenotypic, and genetic evidence of cyclin D1-positive diffuse large B-cell lymphomas with CYCLIN D1 gene rearrangements.
Juskevicius D; Ruiz C; Dirnhofer S; Tzankov A
Am J Surg Pathol; 2014 May; 38(5):719-27. PubMed ID: 24722063
[TBL] [Abstract][Full Text] [Related]
7. BCL-1 rearrangements and p53 mutations in atypical chronic lymphocytic leukemia with t(11;14)(q13;q32).
De Angeli C; Gandini D; Cuneo A; Moretti S; Bigoni R; Roberti MG; Bardi A; Castoldi GL; del Senno L
Haematologica; 2000 Sep; 85(9):913-21. PubMed ID: 10980628
[TBL] [Abstract][Full Text] [Related]
8. Cyclin D1 messenger RNA overexpression as a marker for mantle cell lymphoma.
de Boer CJ; van Krieken JH; Kluin-Nelemans HC; Kluin PM; Schuuring E
Oncogene; 1995 May; 10(9):1833-40. PubMed ID: 7753558
[TBL] [Abstract][Full Text] [Related]
9. Establishment and characterization of a new mantle cell lymphoma cell line, Mino.
Lai R; McDonnell TJ; O'Connor SL; Medeiros LJ; Oudat R; Keating M; Morgan MB; Curiel TJ; Ford RJ
Leuk Res; 2002 Sep; 26(9):849-55. PubMed ID: 12127561
[TBL] [Abstract][Full Text] [Related]
10. The ATM gene in the pathogenesis of mantle-cell lymphoma.
Stilgenbauer S; Schaffner C; Winkler D; Ott G; Leupolt E; Bentz M; Möller P; Müller-Hermelink HK; James MR; Lichter P; Döhner H
Ann Oncol; 2000; 11 Suppl 1():127-30. PubMed ID: 10707794
[TBL] [Abstract][Full Text] [Related]
11. Detection of t(12;14)(p13;q32) in a patient with IGH-CCND1 negative mantle cell lymphoma resembling ultra-high risk chronic lymphocytic leukemia.
Miao Y; Wang R; Fan L; Qiu H; Wu Y; Chen Y; Xu W; Li J
Int J Clin Exp Pathol; 2015; 8(6):7494-8. PubMed ID: 26261659
[TBL] [Abstract][Full Text] [Related]
12. Molecular pathogenesis of mantle cell lymphoma: new perspectives and challenges with clinical implications.
Navarro A; Royo C; Hernández L; Jares P; Campo E
Semin Hematol; 2011 Jul; 48(3):155-65. PubMed ID: 21782057
[TBL] [Abstract][Full Text] [Related]
13. Update on the molecular biology of mantle cell lymphoma.
Bertoni F; Rinaldi A; Zucca E; Cavalli F
Hematol Oncol; 2006 Mar; 24(1):22-7. PubMed ID: 16402392
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of the proteasome induces cell cycle arrest and apoptosis in mantle cell lymphoma cells.
Bogner C; Ringshausen I; Schneller F; Fend F; Quintanilla-Martinez L; Häcker G; Goetze K; Oostendorp R; Peschel C; Decker T
Br J Haematol; 2003 Jul; 122(2):260-8. PubMed ID: 12846895
[TBL] [Abstract][Full Text] [Related]
15. Alterations of the cyclin D1/p16-pRB pathway in mantle cell lymphoma.
Dreyling MH; Bullinger L; Ott G; Stilgenbauer S; Müller-Hermelink HK; Bentz M; Hiddemann W; Döhner H
Cancer Res; 1997 Oct; 57(20):4608-14. PubMed ID: 9377576
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive whole genome array CGH profiling of mantle cell lymphoma model genomes.
de Leeuw RJ; Davies JJ; Rosenwald A; Bebb G; Gascoyne RD; Dyer MJ; Staudt LM; Martinez-Climent JA; Lam WL
Hum Mol Genet; 2004 Sep; 13(17):1827-37. PubMed ID: 15229187
[TBL] [Abstract][Full Text] [Related]
17. Pathologic diagnosis of mantle cell lymphoma.
Lai R; Medeiros LJ
Clin Lymphoma; 2000 Dec; 1(3):197-206; discussion 207-8. PubMed ID: 11707830
[TBL] [Abstract][Full Text] [Related]
18. Mantle cell lymphoma: recent insights into pathogenesis, clinical variability, and new diagnostic markers.
Sander B
Semin Diagn Pathol; 2011 Aug; 28(3):245-55. PubMed ID: 21850989
[TBL] [Abstract][Full Text] [Related]
19. GeneChip analyses point to novel pathogenetic mechanisms in mantle cell lymphoma.
Vater I; Wagner F; Kreuz M; Berger H; Martín-Subero JI; Pott C; Martinez-Climent JA; Klapper W; Krause K; Dyer MJ; Gesk S; Harder L; Zamo A; Dreyling M; Hasenclever D; Arnold N; Siebert R
Br J Haematol; 2009 Feb; 144(3):317-31. PubMed ID: 19016712
[TBL] [Abstract][Full Text] [Related]
20. Delineation of distinct tumour profiles in mantle cell lymphoma by detailed cytogenetic, interphase genetic and morphological analysis.
Katzenberger T; Kienle D; Stilgenbauer S; Höller S; Schilling C; Mäder U; Puppe B; Petzoldt C; Sander S; Bullinger L; Stöcklein H; Kalla J; Hartmann E; Adam P; Ott MM; Müller-Hermelink HK; Rosenwald A; Ott G
Br J Haematol; 2008 Aug; 142(4):538-50. PubMed ID: 18564361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
